Clinical Study on Efficacy and Safety of S-Etodolac Fixed Dose Combination Gel Formulation

Emcure Pharmaceuticals Limited0 个研究点目标入组 90 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Male or female patients between 35 - 65 years of age.
•2. Patients diagnosed to have knee osteoarthritis.
•3. Patients not on any anti-inflammatory or other therapy known to affect the study outcome.
•4. Willing to give written informed consent and willing to comply with the trial protocol.

•1. Patients with known hypersensitivity to the study medications and/or history of any drug allergy or intolerance to NSAIDs.
•2. Patients with the history of or evidence of any severe cardiac, renal, hepatic, neurologic or any other major medical or psychiatric illness.
•3. Any contraindication to use of NSAID.
•4. Women who are pregnant, lactating, of child bearing potential who are not practicing effective methods of contraception.
•5. Drug addiction or alcoholism
•6. Any condition that, in the opinion of the investigator, does not justify the patient?s inclusion in the study.

发起方